Literature DB >> 7504884

Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA.

G J Adema1, A J de Boer, R van 't Hullenaar, M Denijn, D J Ruiter, A M Vogel, C G Figdor.   

Abstract

The glycoproteins recognized by monoclonal antibody (MAb) NKI-beteb are among the best diagnostic markers for human melanoma. MAb NKI-beteb reacts with melanoma cells throughout tumor development and does not cross-react with other tumor or normal cells, except for cells of the melanocytic lineage. Two other melanocyte lineage-specific MAbs, HMB-50 and HMB-45, show a specificity and staining pattern strikingly similar to the ones observed for NKI-beteb. Herein, we demonstrate that all three MAbs recognize protein products encoded by a single cDNA. Expression of this cDNA in BLM cells results in immunoreactivity with all three MAbs. In addition, we demonstrate co-distribution of the RNA species detected by the cDNA with the proteins recognized by the MAbs in tissue sections.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504884      PMCID: PMC1887279     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  19 in total

1.  A monoclonal antibody specific for cells of the melanocyte lineage.

Authors:  C Vennegoor; P Hageman; H Van Nouhuijs; D J Ruiter; J Calafat; P J Ringens; P Rümke
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

2.  Heterogeneous expression of melanoma-associated antigens in uveal melanomas.

Authors:  J P van der Pol; M J Jager; D de Wolff-Rouendaal; P J Ringens; C Vennegoor; D J Ruiter
Journal:  Curr Eye Res       Date:  1987-06       Impact factor: 2.424

3.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

4.  Identification of a secreted Mr 95,000 glycoprotein in human melanocytes and melanomas by a melanocyte specific monoclonal antibody.

Authors:  A M Vogel; R M Esclamado
Journal:  Cancer Res       Date:  1988-03-01       Impact factor: 12.701

5.  Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin.

Authors:  M Eisinger; O Marko
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

6.  Unique proteins defined by monoclonal antibodies specific for human melanoma. Some potential clinical applications.

Authors:  R M Esclamado; A M Gown; A M Vogel
Journal:  Am J Surg       Date:  1986-10       Impact factor: 2.565

7.  Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes.

Authors:  A M Gown; A M Vogel; D Hoak; F Gough; M A McNutt
Journal:  Am J Pathol       Date:  1986-05       Impact factor: 4.307

8.  Expression of the first calcitonin/CGRP gene in spontaneous and transplanted rat medullary thyroid carcinoma: a comparison of dot-blot analysis, in situ hybridization, and immunohistochemistry.

Authors:  M Denijn; R A de Weger; W den Otter; J A van Unnik; C J Lips
Journal:  J Histochem Cytochem       Date:  1992-11       Impact factor: 2.479

9.  Establishment of an ascitic human melanoma cell line that metastasizes to lung and liver in nude mice.

Authors:  M Katano; R E Saxton; A J Cochran; R F Irie
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  23 in total

1.  Repeat domains of melanosome matrix protein Pmel17 orthologs form amyloid fibrils at the acidic melanosomal pH.

Authors:  Ryan P McGlinchey; Frank Shewmaker; Kan-Nian Hu; Peter McPhie; Robert Tycko; Reed B Wickner
Journal:  J Biol Chem       Date:  2010-12-10       Impact factor: 5.157

2.  Premelanosome amyloid-like fibrils are composed of only golgi-processed forms of Pmel17 that have been proteolytically processed in endosomes.

Authors:  Dawn C Harper; Alexander C Theos; Kathryn E Herman; Danièle Tenza; Graça Raposo; Michael S Marks
Journal:  J Biol Chem       Date:  2007-11-08       Impact factor: 5.157

Review 3.  Cytolytic T lymphocyte responses of cancer patients to tumor-associated antigens.

Authors:  P Romero
Journal:  Springer Semin Immunopathol       Date:  1996

4.  The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A).

Authors:  K S Clarkson; I C Sturdgess; A J Molyneux
Journal:  J Clin Pathol       Date:  2001-03       Impact factor: 3.411

Review 5.  Tumor antigens discovery: perspectives for cancer therapy.

Authors:  R F Wang
Journal:  Mol Med       Date:  1997-11       Impact factor: 6.354

Review 6.  The Silver locus product Pmel17/gp100/Silv/ME20: controversial in name and in function.

Authors:  Alexander C Theos; Steven T Truschel; Graça Raposo; Michael S Marks
Journal:  Pigment Cell Res       Date:  2005-10

7.  Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene.

Authors:  Wendy K Steagall; Gustavo Pacheco-Rodriguez; Connie G Glasgow; Yoshihiko Ikeda; Jing-Ping Lin; Gang Zheng; Joel Moss
Journal:  Am J Pathol       Date:  2013-07-16       Impact factor: 4.307

8.  Identification of a melanosomal matrix protein encoded by the murine si (silver) locus using "organelle scanning".

Authors:  B K Zhou; T Kobayashi; P D Donatien; D C Bennett; V J Hearing; S J Orlow
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

9.  Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.

Authors:  Y Kawakami; S Eliyahu; C H Delgado; P F Robbins; K Sakaguchi; E Appella; J R Yannelli; G J Adema; T Miki; S A Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

10.  MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma.

Authors:  Jinyan Du; Arlo J Miller; Hans R Widlund; Martin A Horstmann; Sridhar Ramaswamy; David E Fisher
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.